SPN01 injection safety study for healthy people and colorectal cancer patients
Part of Cancer, Digestive system clinical trials.
This trial tests an injectable drug called SPN01 to see if it is safe and how the body handles it. It includes healthy volunteers and people with colorectal cancer who are scheduled for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old (for healthy volunteers) or 18 to 75 years old (for colorectal cancer patients).
- Your body mass index (BMI) is between 19 and 26, and you meet the minimum weight (50 kg for men, 45 kg for women).
- You are in good general health, with no major diseases or active infections.
- You have not had prior treatment for colorectal cancer (if you are a patient).
- You are willing to use effective contraception during the study and for 30 days after the injection.
- You have not participated in another clinical trial or taken certain medications within the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SNA028 for people with advanced colorectal cancer that has grown after standard treatments. It aims to see if the drug can help shrink tumors or slow the cancer's progression.
This study tests a new medicine called SPOT-mRNA01, given as a small injection under the skin, to see if it is safe and well-tolerated. It is an early-stage trial in healthy volunteers, which means it is not yet testing whether the medicine works for a disease.
This early-phase trial tests a new injection called GB18 in healthy adults to see if it is safe and how the body processes it. It may help researchers understand how to treat conditions that involve the immune system.
This early-stage study tests a new medication called SP-101, given as an intravenous (IV) infusion, in healthy volunteers to see if it is safe and how it is processed by the body. The goal is to find the best dose for future studies.
This study tests a new investigational medicine called SSS67, given as a one-time IV infusion. It is an early-phase trial in healthy volunteers to check how safe the drug is and how the body handles it, and it may help researchers decide if it can be developed for future conditions.
This trial tests a new drug called SPX-303, which is designed to help your immune system fight cancer cells. It is for people with advanced solid tumors that have not responded to other treatments.
Hear when a new Colorectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.